Skip to the page

Data / Form D filings / Recro Pharma, Inc.

Recro Pharma, Inc.: Form D filings

Recro Pharma, Inc., a pharmaceuticals company in Malvern, PA, filed 2 Form D notices with the SEC in 2015. The latest, on July 13, 2015, reports $16 million sold of a $16 million offering to 3 investors.

Find out what Recro Pharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
490 LAPP ROAD, Malvern, PA, 19355
Phone
(484) 395-2400
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Pennsylvania
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1588972

The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 13, 2015New notice$16,000,008$16,000,008$03Jul 1, 2015sec.gov
Apr 23, 2015New notice$7,778,364$7,778,364$02Apr 10, 2015sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Gerri A HenwoodExecutive Officer, Director
Winston J ChurchillDirector
William L AshtonDirector
Abraham J LudomirskiDirector
Alfred A AltomariDirector
Michael L BerelowitzDirector
Donna A NicholsExecutive Officer
Charles A GarnerExecutive Officer
Wayne B WeismanDirector

Other pharmaceuticals companies in Pennsylvania that filed recently

Every Form D from the week of Jul 13, 2015 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Recro Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.